PB2111: SUBGROUP ANALYSIS IN RE-MIND2, AN OBSERVATIONAL, RETROSPECTIVE COHORT STUDY OF TAFASITAMAB + LENALIDOMIDE VERSUS SYSTEMIC THERAPIES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

Detalles Bibliográficos
Autores principales: Nowakowski, G. S., Yoon, D. H., Joffe, E., Zinzani, P. L., Sabatelli, L., Waltl, E. E., Alvero, C. G., Hess, G., Riedell, P., Kim, K., Brixner, D., Salles, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431620/
http://dx.doi.org/10.1097/01.HS9.0000851276.20930.ad

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431620/
http://dx.doi.org/10.1097/01.HS9.0000851276.20930.ad

Ejemplares similares